Business Context and Reporting Period
This Form 8-K Current Report from iSpecimen Inc. (Nasdaq: ISPC) covers events occurring on July 31, 2025, and August 4, 2025. The Company, an emerging growth company incorporated in Delaware, reported the entry into a Material Definitive Agreement involving a private placement of securities.
Key Financial Metrics
- Gross Proceeds: Approximately $1.75 million from the private placement.
- Shares Issued: 1,559,828 shares of Common Stock or Pre-Funded Warrants.
- Purchase Price: $1.122 per share of Common Stock or $1.1219 per Pre-Funded Warrant.
- Placement Agent Fees: 4.0% of gross proceeds paid to WestPark Capital, Inc.
- Marketing Services Fee: $500,000 allocated to IR Agency LLC.
- Debt and Liquidity: The filing does not provide specific values for total debt, cash flow, or liquidity positions outside of the proceeds from this transaction.
Material Changes
The primary material change is the capital raise via a private placement conducted in compliance with Nasdaq Listing Rule 5635(d). This issuance represents 20% or more of the outstanding Common Stock but did not require shareholder approval as it was priced at or above the Nasdaq "Minimum Price." The transaction closed on August 4, 2025.
Guidance, Outlook, and Management Commentary
- Use of Proceeds: The Company intends to use $500,000 of net proceeds for marketing and advertising services provided by IR Agency LLC. The remainder will be used for working capital and general corporate purposes.
- Registration Rights: The Company agreed to file a registration statement for the resale of the issued shares no later than 15 calendar days following the closing date.
- Agreements: Entered into a Securities Purchase Agreement, Registration Rights Agreement, and a one-month Investor Relations Agreement with IR Agency LLC.
- Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond standard disclosure references to the full text of the agreements.
Investor Verification Checklist
- Verify the exact number of shares issued versus Pre-Funded Warrants issued to understand potential dilution.
- Confirm the net proceeds after deducting the 4.0% placement agent fee and other offering expenses.
- Review the full text of the Investor Relations Agreement (Exhibit 10.3) to understand the scope of services for the $500,000 fee.
- Monitor the filing of the registration statement required within 15 days of the August 4, 2025 closing.
- Check subsequent filings for updated cash balance and working capital status post-transaction.